Drug Database
Back to search

Italy· 039365010

VICTOZA*2 penne preriempite SC 3 ml 6 mg/ml

A liraglutide product containing liraglutide, registered in Italy by NOVO NORDISK A/S, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC A10BJ02

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedVICTOZA*2 penne preriempite SC 3 ml 6…ATCA10BJ02REGISTER NO.039365010PACKS LISTED1CHECKEDJune 4, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about liraglutideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Liraglutide is registered in 16 of 19 countries.

Countries holding a registration under ATC A10BJ02 (liraglutide), each read from that country’s own register.

  • This record: Italy
  • 10 of them publish a price we can compare per daily dose
Search liraglutide products by name

Liraglutide · ATC A10BJ02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Active substance
Liraglutide
Manufacturer
NOVO NORDISK A/S
Country
Italy (IT)
ATC code
A10BJ02
ATC class
Liraglutide
Defined daily dose
1.5 mg, P
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    039365010
    VICTOZA*2 penne preriempite SC 3 ml 6 mg/ml
    EUR 131.82

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

309 interactions on record for liraglutide.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check liraglutide against other medicinesHow interaction checks work

Liraglutide · interactions on record

309 records

  • 3 severe
  • 260 moderate
  • 46 minor

Most severe, free to view

  • GatifloxacinJ01MA16severe
  • SucralfateA02BX02moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Liraglutide in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All liraglutide products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Ejulir, Lirabelin
  • Belgium · Byesilor, Zinnentis
  • Bulgaria · Зеглуксен
  • Czechia · Ejulir, Plyzari
  • Germany · Byesilor, Diavic
  • Denmark · Ejulir, Liraglutid "biogaran"
  • Estonia · Liraglutide Zentiva, Siluxir
  • Spain · Byesilor, Diavic
  • Finland · Diavic, Metlyra
  • France · Liendax, Liraglutide Biogaran
  • United Kingdom (Northern Ireland) · Diavic, Ligobesy
  • Croatia · Zegluxen
  • Hungary · Liendax
  • Ireland · Ejulir
  • Iceland · Ablymico, Liraglutide Stada
  • Liechtenstein · Ablymico, Liraglutide Stada
  • Lithuania · Liraglutide Zentiva
  • Luxembourg · Zinnentis
  • Latvia · Liraglutide Zentiva, Siluxir
  • Netherlands · Byesilor, Diavic
  • Norway · Ablymico, Liraglutid Zentiva
  • Poland · Byesilor, Diavic
  • Portugal · Liraglutido Farmoz, Liraglutido Pentafarma
  • Romania · Byesilor, Diavic
  • Sweden · Diavic, Ejulir
  • Slovakia · Sudaclin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bd83c1c2-5b58-4140-918e-74c050cb7a5c
GET /v1/drugs/bd83c1c2-5b58-4140-918e-74c050cb7a5c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 131.82,
  "source": "aifa",
  "currency": "EUR",
  "strength": "LIRAGLUTIDE 6MG/ML 3ML 2 UNITA' USO PARENTERALE",
  "substance": "Liraglutide",
  "equivalence_group": "O4A",
  "transparency_flag": null
}
API referenceMCP serverPlans

See everything about liraglutide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console